Michel Moise Habib

Directeur/Membre du Conseil chez EPITOMEE MEDICAL LTD

Profil

Michel is a seasoned Venture Capitalist and senior executive investing in MedTech & Biotech, expert in value building throughout the whole spectrum of tech companies development, with a track record of successful exits of over 1.5 $Bn.
Former advisor to CBG Ltd, a multi Billion, London based, family office.
Former CEO of Hadasit Bio-Holdings (HDST), member of the BOD of Epitomee (Strategic deal with Nestle Health Science (TASE IPO, EPIT), former member of the BOD of Enlivex (Nasdaq, ENLV), Kahr Medical, Minovia, Omnix, Eximore, Meditate (Acquired by Olympus $309M), Xenia Ventures and VLX Incubator, served as Chairman of Cellcure (Nasdaq, LCTX) (Acquired by Roche Genentech $670M) and led investment in Adicet Bio (Nasdaq ACET).
Former Managing General Partner at MaC LP VC Funds, with over $100M under management, with significant exits (Lumenis, MST, Endochoice, Peptron).
Former Elron's BD Director, managing the Medical Devices sector (Medingo, Given Imaging).
Established and managed the Israel investment banking activity of ING Barings, served as VP Investment Banking at Cukierman & Co. During the 90's served as Israel’s Economic Consul in Boston, and as Commercial Attaché to South Korea.
As Officer (Academic Reserve, Captain Res.) in the IDF Navy, managed development of advanced Naval systems for the Navy's elite unit.
Mr. Habib holds a BsC in Aeronautical Engineering from the Technion.
He is a graduate from Israel's foreign service economic cadet school, member of the Technion Alumni "100 Club” and graduate from the Global Executive Program on Negotiation (PON) at Harvard Law School.
Michel is a graduate and member of the 8400 Health Network.

Postes actifs de Michel Moise Habib

Sociétés	Poste	Début
EPITOMEE MEDICAL LTD	Directeur/Membre du Conseil	01/01/2018
Alive Israel Healthtech Fund	Fondateur	01/07/2020
BioProtect Ltd.	Directeur/Membre du Conseil	-
Eximore Ltd.	Directeur/Membre du Conseil	-
Omnix Medical Ltd.	Directeur/Membre du Conseil	-
Matar Capital Advisors Ltd.	Directeur Général	01/08/2006
KAHR Medical Ltd.	Directeur/Membre du Conseil	01/04/2016
Hadasit Bio-Holdings Ltd. /Private Equity/	Directeur Général	-

Anciens postes connus de Michel Moise Habib

Sociétés	Poste	Fin
HBL - HADASIT BIO-HOLDINGS LTD	Directeur Général	31/03/2020
░░░░░ ░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░ ░░░░░░ ░░░░░░░░	░░░░░░░░░░
░░░░░░░░ ░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░
░░░░░░░░░░ ░░░░	░░░░░░░░░░░░░░░░ ░░ ░░░░░░░	░░░░░░░░░░